Derangement of apoptosis in cancer

This publication has 14 references indexed in Scilit:

• Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
  The Journal of Experimental Medicine, 2001
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
  Nature, 2001
• A Novel AP-1 Element in the CD95 Ligand Promoter Is Required for Induction of Apoptosis in Hepatocellular Carcinoma Cells upon Treatment with Anticancer Drugs
  Molecular and Cellular Biology, 2000
• Molecular insights into the immunopathogenesis of follicular lymphoma
  Immunology Today, 2000
• Mitochondrial control of cell death
  Nature Medicine, 2000
• Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
  Oncogene, 2000
• Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
  The Journal of Experimental Medicine, 1999
• p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
  The Journal of Experimental Medicine, 1998
• Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
  Current Opinion in Immunology, 1998
• CD95(APO-1/Fas)-Mediated Apoptosis: Live and Let Die
  Published by Elsevier ,1998